A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia

Clinical trial NCT07295951 · RECRUITING

Trial details

NCT number: NCT07295951
Sponsor: Janssen Research & Development, LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Acute Leukemias Acute Myeloid Leukemia

Start date: 2025-11-18
Primary completion: 2026-09-29
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.